Manufacturer record
Gufic Biosciences Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Gufic Biosciences Limited (Karnataka) were declared Not of Standard Quality between April 2024 and March 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: AB250491A, Liposomal Amphotericin B Injection 50 Mg (exp Aug 2027). RDTL, Chandigarh (CDSCO lab) found it not of standard quality: The sample does not conform to claim as per Patent and Proprietary and IS 10654:2002 in respect to the Test of pH, Free drug. Listed in the March 2026 alert.
Records by type
2 records linked to Gufic Biosciences Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Liposomal Amphotericin B Injection 50 Mg | Batch AB250491AMfg Sep 2025 · Exp Aug 2027 | The sample does not conform to claim as per Patent and Proprietary and IS 10654:2002 in respect to the Test of pH, Free drugpH | RDTL, ChandigarhCDSCO lab | Mar 2026 |
| Sallaki Tablets | Batch AB 23055Mfg Nov 2023 · Exp Oct 2026 | The sample fails the test Disintegration as per APIDisintegration | SDTL ThiruvananthapuramState lab | Apr 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.